"Myopic macular degeneration Market Analysis"In the 7MM, the Myopic Macular Degeneration market size mainly consisted of anti-VEGF therapies and standard of care which generated nearly ~USD 734 ...
Co announces positive results from a Phase II investigator-sponsored study of the company's drug, IPLEX, in patients with myotonic muscular dystrophy. Preliminary results of the clinical study showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback